[A personalized, evidence-based approach to obesity therapy using clinical algorithms: semaglutide or tirzepatide]. [PDF]
Probl Endokrinol (Mosk)Troshina EA +7 more
europepmc +1 more source
[Synergistic effects of GABA and hypoglycemic drugs]. [PDF]
Probl Endokrinol (Mosk), 2023 Tyurenkov IN +2 more
europepmc +1 more source
[The relationship between Parkinson's disease and metabolic disorders: the impact of systemic dysfunctions on neurodegeneration]. [PDF]
Probl Endokrinol (Mosk)Yusupov FA, Abdykadyrov MS.
europepmc +1 more source
[Hypophysitis and reversible hypopituitarism developed after COVID-19 infection - a clinical case report]. [PDF]
Probl Endokrinol (Mosk), 2022 Gorbova NY +3 more
europepmc +1 more source
[Immunometabolic disorders in type 2 diabetes mellitus mediated by NLRP3 inflammasome activation and methods of pharmacological correction thereof]. [PDF]
Probl Endokrinol (Mosk)Cheplyaeva NI +4 more
europepmc +1 more source
[Immunological status in patients with amenorrhea (literature review)]. [PDF]
Probl Endokrinol (Mosk)Absatarova YS +6 more
europepmc +1 more source
[The role of leptin in endometrium disorders: literature review]. [PDF]
Probl Endokrinol (Mosk)Ievleva KD, Danusevich IN, Suturina LV.
europepmc +1 more source
[Cystic fibrosis being a polyendocrine disease (Review)]. [PDF]
Probl Endokrinol (Mosk), 2021 Chagay NB +3 more
europepmc +1 more source
[Factors and conditions affecting transcortin production and function in blood plasma]. [PDF]
Probl Endokrinol (Mosk)Chevais A +7 more
europepmc +1 more source
[Contraception in adolescents with obesity and diabetes mellitus]. [PDF]
Probl Endokrinol (Mosk), 2022 Shaydullina MR +3 more
europepmc +1 more source